M. Matheson

发表

A phase IV, multi-centre, randomized clinical trial comparing two pertussis-containing vaccines in pregnant women in England and vaccine responses in their infants

A. Khalil, N. Andrews, C. Jones, 2021, BMC Medicine.

Recombinant Neisseria meningitidis Transferrin Binding Protein A Protects against Experimental Meningococcal Infection

S. Funnell, A. Gorringe, A. Robinson, 2001, Infection and Immunity.

Longitudinal antibody and T cell responses in Ebola virus disease survivors and contacts: an observational cohort study

P. Maes, S. Günther, S. K. Fehling, 2020, The Lancet Infectious Diseases.

Phase I Safety and Immunogenicity Study of a Candidate Meningococcal Disease Vaccine Based on Neisseria lactamica Outer Membrane Vesicles

N. Andrews, R. Read, C. Evans, 2009, Clinical and Vaccine Immunology.

vaccine based on Neisseria lactamica outer membrane vesicles.

J. Findlow, R. Borrow, A. Gorringe, 2009 .

Group B streptococcus (GBS) colonisation among expectant Irish mothers.

K. Butler, A. Efstratiou, M. Matheson, 1998, Irish medical journal.

Serological responses to Anthrax Vaccine Precipitated (AVP) increase with time interval between booster doses.

E. Williamson, B. Hallis, R. J. Gwyther, 2022, Vaccine.

Immunogenicity of the UK group B meningococcal vaccine (4CMenB) schedule against groups B and C meningococcal strains (Sched3): outcomes of a multicentre, open-label, randomised controlled trial.

N. Andrews, D. Goldblatt, M. Snape, 2021, The Lancet. Infectious diseases.

A phase IV, multi-centre, randomized clinical trial comparing two pertussis-containing vaccines in pregnant women in England and vaccine responses in their infants

A. Khalil, N. Andrews, C. Jones, 2021, BMC Medicine.

Nasopharyngeal colonization by Neisseria lactamica and induction of protective immunity against Neisseria meningitidis.

R. Read, C. Evans, J. Findlow, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The development of a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.

A. Gorringe, M. Matheson, K. Reddin, 2005, Vaccine.

Immunogenicity of a Single Dose of Meningococcal Group C Conjugate Vaccine Given at 3 Months of Age to Healthy Infants in the United Kingdom

N. Andrews, D. Goldblatt, E. Miller, 2012, The Pediatric infectious disease journal.

Safety and Immunogenicity of Coadministering a Combined Meningococcal Serogroup C and Haemophilus influenzae Type b Conjugate Vaccine with 7-Valent Pneumococcal Conjugate Vaccine and Measles, Mumps, and Rubella Vaccine at 12 Months of Age

N. Andrews, D. Goldblatt, E. Miller, 2010, Clinical and Vaccine Immunology.

Isolation of the gene and large-scale expression and purification of recombinant Erythrina cristagalli lectin.

C. Shone, J. Chaddock, M. Matheson, 2003, Protein expression and purification.

Randomized Trial to Compare the Immunogenicity and Safety of a CRM or TT Conjugated Quadrivalent Meningococcal Vaccine in Teenagers who Received a CRM or TT Conjugated Serogroup C Vaccine at Preschool Age

N. Andrews, E. Miller, P. Waight, 2015, The Pediatric infectious disease journal.

Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator.

N. Andrews, D. Goldblatt, S. Ladhani, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Isolation of a putative fimbrial adhesin from Bordetella pertussis and the identification of its gene

F. Mooi, R. Willems, R. Ebberink, 1993, Molecular Microbiology.

Acellular Pertussis Vaccines Induce Anti-pertactin Bactericidal Antibodies Which Drives the Emergence of Pertactin-Negative Strains

E. Lesne, C. V. van Els, A. Gorringe, 2020, Frontiers in Microbiology.

A Randomized Trial Assessing the Immunogenicity and Reactogenicity of Two Hexavalent Infant Vaccines Concomitantly Administered With Group B Meningococcal Vaccine

P. Aley, D. Goldblatt, M. Snape, 2022, The Pediatric infectious disease journal.

Antibody Responses to Individual Bordetella pertussis Fimbrial Antigen Fim2 or Fim3 following Immunization with the Five-Component Acellular Pertussis Vaccine or to Pertussis Disease

A. Gorringe, N. Fry, M. Matheson, 2012, Clinical and Vaccine Immunology.

immunisation with five component acellular pertussis vaccine or disease.

A. Gorringe, N. Fry, M. Matheson, 2012 .

Interchangeability of meningococcal group C conjugate vaccines with different carrier proteins in the United Kingdom infant immunisation schedule.

N. Andrews, D. Goldblatt, S. Ladhani, 2015, Vaccine.

Optimising the Timing of whooping cough Immunisation in MUMs: a randomised controlled trial investigating the timing of pertussis vaccination in pregnancy (OpTIMUM): a protocol paper

A. Khalil, N. Andrews, C. Jones, 2019, Wellcome Open Research.

Pertussis Antibody Concentrations in Infants Born Prematurely to Mothers Vaccinated in Pregnancy

N. Andrews, S. Ladhani, E. Miller, 2016, Pediatrics.

An observational, cohort, multi-centre, open label phase IV extension study comparing preschool DTAP-IPV booster vaccine responses in children whose mothers were randomised to one of two pertussis-containing vaccines or received no pertussis-containing vaccine in pregnancy in England.

N. Andrews, C. Jones, M. Snape, 2022, Vaccine.

Estimation of ELISA results using a parallel curve analysis.

B. Hallis, A. Yellowlees, F. Bursa, 2020, Journal of immunological methods.

Optimising the Timing of whooping cough Immunisation in MUMs: a randomised controlled trial investigating the timing of pertussis vaccination in pregnancy (OpTIMUM): a protocol paper

A. Khalil, N. Andrews, C. Jones, 2021, Wellcome Open Research.

Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator.

N. Andrews, D. Goldblatt, S. Ladhani, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Optimising the timing of whooping cough immunisation in mums (OpTIMUM) through investigating pertussis vaccination in pregnancy: an open-label, equivalence, randomised controlled trial.

E. Johnstone, M. Coleman, C. Jones, 2023, The Lancet. Microbe.